Metabolic and hormonal profiling in polycystic ovarian syndrome: insights into INSR gene variations
Authors:
- 17 September 2024
- journal article
- research article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 51 (1) , 1-10
Abstract
Background Polycystic Ovary Syndrome (PCOS) is a hormonal disorder characterized by irregular periods, excess androgen levels, and polycystic ovaries, affecting many women of reproductive age. Methods and Results This study employed statistical and molecular analyses to compare hormone and metabolic markers between PCOS patients and controls. Sanger sequencing identified two INSR gene variants linked to high insulin and pre-diabetic conditions. Statistically, no significant age differences were detected (p = 0.492) between the overall PCOS patient pool and controls. However, a substantial variation in Vitamin D levels was observed within PCOS patients compared to controls (p = 0.0006), suggesting an association with PCOS. Correlations between Vitamin D and insulin, as well as HbA1c levels (R2 = 0.141 and 0.143, respectively), suggest Vitamin D’s potential impact on glycemic control. Significant differences were found in HbA1c (p < 0.0001), insulin (p < 0.0001), and LDL (p = 0.0004) levels between PCOS patients and controls, highlighting marked disparities in these metabolic markers. LH levels also showed a significant contrast (p < 0.0001), while progesterone levels displayed a notable difference (p = 0.007) between the two groups. Correlation analyses within PCOS patients demonstrated associations among LDL, HbA1c, and insulin, with no such correlations observed in control cases. Additionally, Sanger sequencing identified two INSR gene variants, c.3614C > T (p.Pro1205Leu) and c.3355C > T (p.Arg1119Trp), associated with high insulin, LH, and pre-diabetic conditions. These amino acid changes may trigger metabolic imbalances and hormonal irregularities, potentially contributing to the development of PCOS. Conclusions The findings highlight the multifaceted nature of PCOS, revealing significant metabolic, hormonal, and genetic differences compared to controls. These insights may inform tailored interventions and management strategies for the complex associations characteristic of PCOS.Keywords
This publication has 48 references indexed in Scilit:
- FastPCR: An in silico tool for fast primer and probe design and advanced sequence analysisGenomics, 2017
- Genetic Studies on Polycystic Ovary SyndromeBest Practice & Research Clinical Obstetrics & Gynaecology, 2016
- HbA1c in Patients with Polycystic Ovary Syndrome: A Potential Marker of Inflammation2016
- MECHANISMS IN ENDOCRINOLOGY: Thyroid and polycystic ovary syndromeEuropean Journal of Endocrinology, 2015
- Sequencing analysis of insulin receptor defects and detection of two novel mutations in INSR geneMolecular Genetics and Metabolism Reports, 2014
- Polycystic ovary syndrome: a review of treatment options with a focus on pharmacological approaches.2013
- Replication of association of a novel insulin receptor gene polymorphism with polycystic ovary syndromeFertility and Sterility, 2011
- Insulin Gene Polymorphism in Women with Polycystic Ovary SyndromeJournal of International Medical Research, 2008
- A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndromeFertility and Sterility, 2008
- A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndromeFertility and Sterility, 2002